| Literature DB >> 27517938 |
Chih-Hua Chao1,2, Chia-Yun Wu3, Chiung-Yao Huang4, Hui-Chun Wang5,6,7, Chang-Feng Dai8, Yang-Chang Wu9,10,11, Jyh-Horng Sheu12,13,14,15.
Abstract
Two new cubitanoids, nanoculones A and B (1 and 2), and three new cembranoids, nanolobols A-C (3-5), as well as six known compounds, calyculone I (6), sinulariuol A (7), sinulariols C, D, H, and J (8-11), were isolated from the soft coral Sinularia nanolobata, collected off the coast of the eastern region of Taiwan. Their structures were elucidated on the basis of extensive spectroscopic analysis. Cytotoxicity of compounds 1-11 was evaluated. The nitric oxide (NO) inhibitory activity of selected compounds was further measured by assay of lipopolysaccharide (LPS)-stimulated NO production in activated RAW264.7 cells. The results showed that none of 1-11 exhibited cytotoxicity against the tested cancer cell lines, whereas compound 8 was found to significantly reduce NO production.Entities:
Keywords: Sinularia; cubitane; nanoculones A and B; nanolobols A–C
Mesh:
Substances:
Year: 2016 PMID: 27517938 PMCID: PMC4999911 DOI: 10.3390/md14080150
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–5.
Figure 2X-ray structure of 6.
1H and 13C NMR spectroscopic data of compounds 1 and 2.
| Position | 1 | 2 | ||
|---|---|---|---|---|
| δH ( | δC (mult.) | δH ( | δC (mult.) | |
| 1 | 1.95 m | 27.8, CH | 2.06 m | 29.2, CH |
| 2 | 1.54 m | 33.9, CH2 | 1.48 m | 30.3, CH2 |
| 1.24 m | ||||
| 3 | 1.98 m | 25.9, CH2 | 1.93 m | 24.9, CH2 |
| 1.30 m | 1.24 m | |||
| 4 | 2.77 dd (9.2, 3.6) | 62.5, CH | 2.61 dd (10.0, 2.8) | 64.6, CH |
| 5 | 62.3, C | 60.2, C | ||
| 6 | 2.30 m | 35.7, CH2 | 2.06 m | 35.1, CH2 |
| 1.39 m | 1.62 m | |||
| 7 | 2.58 m | 25.9, CH2 | 2.21 m | 27.5, CH2 |
| 2.10 m | 2.09 m | |||
| 8 | 147.1, C | 147.7, C | ||
| 9 | 5.45 d (10.0) | 120.4, CH | 5.20 d (10.8) | 119.3, CH |
| 10 | 4.21 d (10.0) | 57.7, CH | 4.08 d (10.8) | 60.5, CH |
| 11 | 209.7, C | 208.7, C | ||
| 12 | 2.63 dd (14.8, 6.4) | 52.6, CH2 | 2.54 dd (11.6, 2.8) | 48.4, CH2 |
| 2.28 m | 1.68 m | |||
| 13 | 0.89 d (6.4) | 20.6, CH3 | 0.95 d (6.4) | 20.7, CH3 |
| 14 | 1.16 s | 19.0, CH3 | 1.31, s | 18.0, CH3 |
| 15 | 2.40 m | 30.3, CH | 2.87 m | 29.6, CH |
| 16 | 1.08 d (6.4) | 20.5, CH3 | 1.07 d (7.0) | 21.7, CH3 |
| 17 | 0.98 d (6.4) | 23.0, CH3 | 1.01 d (7.0) | 21.4, CH3 |
| 18 | 143.0, C | 147.7, C | ||
| 19 | 1.70 s | 21.2, CH3 | 1.75 s | 22.2, CH3 |
| 20 | 4.85 s | 112.6, CH2 | 4.99 s | 112.7, CH2 |
| 4.80 s | 4.90 s | |||
Spectra recorded at 400 MHz in CDCl3; Spectra recorded at 100 MHz in CDCl3.
Figure 3Selected 1H–1H COSY and HMBC correlations of 1 and 2.
Figure 4Selected NOE correlations of compounds 1 and 2.
1H and 13C NMR spectroscopic data of 3–5.
| Position | 3 | 4 | 5 | |||
|---|---|---|---|---|---|---|
| δH ( | δC (mult.) | δH ( | δC (mult.) | δH ( | δC (mult.) | |
| 1 | 151.8, C | 151.8, C | 78.3, C | |||
| 2 | 5.09 d (10.0) | 118.2, CH | 4.99 d (6.8) | 119.2, CH | 5.67 d (16.0) | 126.8, CH |
| 3 | 5.49 d (10.0) | 74.8, CH | 3.33 d (6.8) | 59.5, CH | 6.01 d (16.0) | 140.8, CH |
| 4 | 74.0, C | 61.3, C | 73.5, C | |||
| 5 | 1.70 m | 36.6, CH2 | 2.08 m | 38.0, CH2 | 1.96 m | 43.6, CH2 |
| 1.59 m | 1.47 m | 1.68 m | ||||
| 6 | 2.61 m | 23.6, CH2 | 2.31 m | 22.0, CH2 | 2.35 m | 23.6, CH2 |
| 2.12 m | 2.09 m | 2.21 m | ||||
| 7 | 5.47 t (7.6) | 131.7, CH | 5.48 t (7.6) | 129.9, CH | 5.32 t (7.5) | 134.2, CH |
| 8 | 137.7, C | 137.6, C | 135.0, C | |||
| 9 | 2.34 m | 34.7, CH2 | 2.61 m | 32.6, CH2 | 2.33 m | 34.6, CH2 |
| 2.23 m | 2.05 m | 2.12 m | ||||
| 10 | 2.15 m | 24.6, CH2 | 2.14 m | 24.8, CH2 | 1.66 m | 27.3, CH2 |
| 1.44 m | 1.37 m | 1.52 m | ||||
| 11 | 3.20 dd (9.6, 2.8) | 62.2, CH | 2.73 dd (10.0, 4.0) | 61.9, CH | 3.61 dd (8.0, 1.5) | 72.6, CH |
| 12 | 61.6, C | 61.3, C | 81.9, C | |||
| 13 | 2.10 m | 40.1, CH2 | 2.17 m | 38.3, CH2 | 2.46 dt (11.5, 3.5) | 31.5, CH2 |
| 0.98 m | 1.19 m | 1.91 m | ||||
| 14 | 2.30 m | 27.0, CH2 | 2.17 m | 27.4, CH2 | 1.86 m | 26.4, CH2 |
| 1.97 m | 1.49 m | |||||
| 15 | 2.34 m | 35.3, CH | 2.27 m | 34.0, CH | 1.85 m | 39.1, CH |
| 16 | 1.03 d (6.8) | 21.8, CH3 | 1.03 d (6.8) | 21.8, CH3 | 0.77 d (7.0) | 17.2, CH3 |
| 17 | 1.03 d (6.8) | 22.1, CH3 | 1.04 d (6.8) | 22.3, CH3 | 0.92 d (7.0) | 16.5, CH3 |
| 18 | 1.13 s | 23.9, CH3 | 1.25 s | 18.0, CH3 | 1.30 s | 29.4, CH3 |
| 19 | 4.36 d (12.8) | 59.5, CH2 | 4.29 d (12.0) | 58.8, CH2 | 4.24 d (12.0) | 60.2, CH2 |
| 4.01 d (12.8) | 4.18 d (12.0) | 4.10 d (12.0) | ||||
| 20 | 1.28 s | 16.3 CH3 | 1.29 s | 16.5 CH3 | 1.44 s | 16.8 CH3 |
| OAc | 170.9, C | 170.2, C | ||||
| 2.07 s | 21.4, CH3 | 1.98 s | 22.4, CH3 | |||
Spectra recorded at 400 MHz in CDCl3; Spectra recorded at 100 MHz in CDCl3; Spectra recorded at 500 MHz in CDCl3; Spectra recorded at 125 MHz in CDCl3.
Figure 5Selected NOE correlations of 4 and 5.
Figure 6Structures of compounds 6–11.
Figure 7Nitric oxide (NO) production and cell viabilities of compounds 1–4, 6–8, 10, and 11 in LPS-stimulated RAW264.7 cells (A) at 100 μM (B) at 50 μM. AG: aminoguanidine is used as a positive control.